Newsletters

LATEST NEWS

Client Alert – Justice Department Reports FCA Recoveries for FY2019

Jan 14, 2020
  • FisherBroyles News
  • Pharmacy Law

New Legal Exposures Appearing for Makers and Sellers of CBD Products

Nov 12, 2019
  • FisherBroyles News
  • Pharmacy Law

Client Alert – FDA Issues More Warning Letters Regarding the Marketing of Cannabidiol-Containing Product

Sep 11, 2019
  • FisherBroyles News
  • Pharmacy Law

Health Care Continues to Predominate in False Claims Act Settlements with DOJ

Jul 22, 2019
  • FisherBroyles News
  • Pharmacy Law

Client Alert – White House Withdraws Proposed Rebate Rule

Jul 17, 2019
  • FisherBroyles News
  • Pharmacy Law

Client Alert – Florida Court Holds the State’s Medical Marijuana Statute Unconstitutional

Jul 11, 2019
  • FisherBroyles News
  • Pharmacy Law

Client Alert – Reverse Pharmaceutical Distributor and Execs Hit with Heavy Penalties for Fraudulent Scheme

Jul 08, 2019
  • FisherBroyles News
  • Pharmacy Law

Client Alert – FDA Takes First Look at Issues Involved in CBD Regulation

Jun 14, 2019
  • FisherBroyles News
  • Pharmacy Law

Client Alert – The First, But Maybe Not The Last? Feds Convict Insys Execs in Opioid Racketeering Case

May 03, 2019
  • FisherBroyles News
  • Pharmacy Law

Client Alert – DOJ Criminal Division Releases Guidance on Evaluation of Corporate Compliance Programs

May 03, 2019
  • FisherBroyles News
  • Pharmacy Law

Client Alert – FTC Accuses Surescripts of Anticompetitive Tactics

Apr 26, 2019
  • FisherBroyles News
  • Pharmacy Law

Feds Take Down $1.2 Billion Telemedicine and DME Fraud Scheme

Apr 12, 2019
  • FisherBroyles News
  • Health Care
  • Pharmacy Law

FDA Schedules Hearings on Cannabis Regulation

Apr 11, 2019
  • FisherBroyles News
  • Health Care
  • Pharmacy Law

FisherBroyles Welcomes Health & Pharmacy Law Partner Janna King in Houston

Jan 02, 2019
  • Pharmacy Law

Government Achieves Another Round of Convictions in New England Compounding Center Case

Dec 20, 2018
  • FisherBroyles News
  • Pharmacy Law

Client Alert – CMS Rule Change Could Cost Medicare Advantage Plans Billions

Nov 02, 2018
  • FisherBroyles News
  • Pharmacy Law